Meloxicam (under the brand name Mobicox) is a new arthritis drug. Unlike other COX-II selective nonsteroidal anti-inflammatory drugs (NSAID) known as coxibs, Meloxicam, an oxicam COX-2 selective NSAID, is a unique class of COX-II selective NSAIDs that appear to not carry the same risk of blood clots that other coxibs have.